Did you read the recent investor preso? ..From P25: (All of...

Did you read the recent investor preso? ..From P25: (All of these will impact the share price)

* OA Phase 2b trial results released. Partnering Discussions Commence
* Release Secondary End-point data front the OA Phase 2b trial – Q1/Q2 2019
* Potential to treat to MPS patients in Australia via the SAS – Q1/Q2 CY2019
* Up to 50 ex-NFL players in the US to be treated with iPPS for OA pain
* Potential for significant media attention if treatment is successful – Q1/Q2 CY2019
* File IND for Phase 2/3 for Mucopolysaccharidosis (MPS) - Q2 CY201
* Further release of patients OA data under the TGA special access scheme
throughout 2019
* File TGA Provisional Approval to sell ZILUSOL (iPPS) in Australia
* Q2 CY2019 Ø Ross River Phase 2a (safety study) trial results release – Q2/Q3 CY2019

...to name just a few